PTAB Rightfully Rejected Merck Patent App, Fed. Circ. Says
The Federal Circuit on Wednesday backed the Patent Trial and Appeal Board in rejecting a Merck & Cie patent application, finding that prior art had outlined the same process for preventing...To view the full article, register now.
Already a subscriber? Click here to view full article